mozavaptan has been researched along with atrial natriuretic factor in 3 studies
| Studies (mozavaptan) | Trials (mozavaptan) | Recent Studies (post-2010) (mozavaptan) | Studies (atrial natriuretic factor) | Trials (atrial natriuretic factor) | Recent Studies (post-2010) (atrial natriuretic factor) |
|---|---|---|---|---|---|
| 165 | 8 | 24 | 15,455 | 1,105 | 1,760 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shimizu, K | 1 |
| Abe, K; Funyu, T; Inoue, M; Kimura, T; Ohta, M; Ota, K; Sato, K; Shoji, M; Yamamoto, T | 1 |
| Bie, P; Mølstrøm, S; Wamberg, S | 1 |
1 trial(s) available for mozavaptan and atrial natriuretic factor
| Article | Year |
|---|---|
Aquaretic effects of the nonpeptide V2 antagonist OPC-31260 in hydropenic humans.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aldosterone; Angiotensin II; Antidiuretic Hormone Receptor Antagonists; Arginine Vasopressin; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Calcium; Creatinine; Dinoprostone; Epinephrine; Heart Rate; Humans; Male; Norepinephrine; Osmolar Concentration; Phosphates; Potassium; Sodium; Thromboxane B2; Uric Acid; Urine; Water; Water Deprivation | 1995 |
2 other study(ies) available for mozavaptan and atrial natriuretic factor
| Article | Year |
|---|---|
Effects of V1- and V2-vasopressin (AVP) antagonists on the pressor, AVP and atrial natriuretic peptide responses to a hypertonic saline infusion in conscious anephric rats.
Topics: Animals; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Heart Rate; Hemodynamics; Kidney; Male; Nephrectomy; Neurons, Afferent; Osmolar Concentration; Piperidines; Plasma Volume; Quinolones; Radioimmunoassay; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Saline Solution, Hypertonic; Vasopressins | 1995 |
Normotensive sodium loading in conscious dogs: regulation of renin secretion during beta-receptor blockade.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Animals; Antidiuretic Hormone Receptor Antagonists; Atrial Natriuretic Factor; Benzazepines; Blood Pressure; Consciousness; Diet, Sodium-Restricted; Dogs; Female; Glomerular Filtration Rate; Heart Rate; Hormone Antagonists; Infusions, Intravenous; Juxtaglomerular Apparatus; Metoprolol; Natriuresis; Norepinephrine; Potassium; Receptors, Adrenergic, beta-1; Receptors, Vasopressin; Renin; Renin-Angiotensin System; Sodium; Sodium Chloride; Sympathetic Nervous System; Time Factors | 2009 |